Drug Interactions Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Drug Interactions. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Drug Interactions Indian Medical PG Question 1: Which of the following statements is true regarding competitive reversible antagonism?
- A. ED50 remains unchanged in competitive reversible antagonism.
- B. Efficacy and Vmax remain unchanged. (Correct Answer)
- C. Potency remains unchanged in the presence of a competitive antagonist.
- D. Affinity (Kd) remains unchanged in competitive reversible antagonism.
Drug Interactions Explanation: ***Efficacy and Vmax remain unchanged.***
- In competitive reversible antagonism, the antagonist binds to the same receptor site as the agonist but can be overcome by increasing the agonist concentration [2]. This means the **maximum effect (efficacy or Vmax)** of the agonist can still be achieved, although a higher dose is needed [2].
- The antagonist does not alter the intrinsic ability of the agonist to produce a full response, only its **apparent affinity** for the receptor.
- This is the hallmark of competitive reversible antagonism: **rightward shift of the dose-response curve with no change in maximum response** [2].
*Potency remains unchanged in the presence of a competitive antagonist.*
- **Potency** is a measure of the amount of drug needed to produce a given effect (often defined by EC50 or ED50) [3].
- A competitive antagonist requires a **higher concentration of agonist** to achieve the same effect, thus **decreasing the apparent potency** of the agonist [4].
- The dose-response curve shifts to the right (parallel shift) [4].
*ED50 remains unchanged in competitive reversible antagonism.*
- **ED50 (effective dose 50)** is the dose that produces 50% of the maximum effect.
- Because competitive antagonists shift the dose-response curve to the right, a **higher ED50** is required to achieve 50% of the maximum effect in the presence of an antagonist [4].
*Affinity (Kd) remains unchanged in competitive reversible antagonism.*
- The **dissociation constant (Kd)** represents the affinity of a drug for its receptor [1].
- In competitive reversible antagonism, the antagonist increases the **apparent Kd** of the agonist (reduces apparent affinity), requiring more agonist to achieve receptor occupancy.
- The **intrinsic Kd** of the agonist doesn't change, but its apparent affinity is reduced due to competition with the antagonist.
Drug Interactions Indian Medical PG Question 2: A factor that is likely to increase the duration of action of a drug that is partially metabolized by CYP3A4 in the liver is:
- A. Chronic administration of phenobarbital with the drug
- B. Displacement from tissue binding sites by another drug
- C. Chronic administration of rifampicin
- D. Chronic administration of cimetidine with the drug (Correct Answer)
Drug Interactions Explanation: ***Chronic administration of cimetidine with the drug***
- **Cimetidine** is a potent inhibitor of various **cytochrome P450 (CYP450) enzymes**, including **CYP3A4**.
- By inhibiting the metabolism of a drug predominantly metabolized by **CYP3A4**, cimetidine will increase its plasma concentration and extend its **duration of action**.
*Chronic administration of phenobarbital with the drug*
- **Phenobarbital** is a strong **inducer of CYP450 enzymes**, including **CYP3A4**.
- Induction would accelerate the metabolism of the drug, thus **decreasing its duration of action**, not increasing it.
*Displacement from tissue binding sites by another drug*
- Displacement from tissue binding sites would primarily increase the **free fraction of the drug in the plasma**, leading to a more rapid distribution to eliminating organs and potentially **shorter duration of action** if elimination is extraction-limited.
- This mechanism does not directly impact the **metabolic rate** unless clearance is significantly altered through increased availability for metabolism.
*Chronic administration of rifampicin*
- **Rifampicin** is a potent **inducer of CYP3A4** and other CYP enzymes.
- Its administration would lead to **increased metabolism** of the co-administered drug, thereby **reducing its duration of action**.
Drug Interactions Indian Medical PG Question 3: A patient on warfarin has a high INR. Which drug likely caused this?
- A. Amiodarone (Correct Answer)
- B. Phenytoin
- C. Carbamazepine
- D. Rifampicin
Drug Interactions Explanation: ***Amiodarone***
- Amiodarone is a well-known inhibitor of **CYP2C9**, the primary enzyme responsible for the metabolism of **S-warfarin**, the more potent enantiomer of warfarin.
- Inhibition of warfarin metabolism leads to increased warfarin levels, thereby enhancing its anticoagulant effect and causing a **higher INR**.
*Phenytoin*
- Phenytoin is an **enzyme inducer**, primarily of **CYP2C9** and **CYP3A4**.
- Its interaction with warfarin typically leads to **decreased warfarin levels** and a **lower INR**, reducing the anticoagulant effect.
*Carbamazepine*
- Carbamazepine is a potent **enzyme inducer**, particularly of **CYP3A4** and **CYP2C9**.
- Like phenytoin, it generally leads to **increased warfarin metabolism** and a **reduced INR**, thereby decreasing its anticoagulant efficacy.
*Rifampicin*
- Rifampicin is a strong **inducer of hepatic cytochrome P450 enzymes**, especially **CYP3A4** and **CYP2C9**.
- Its co-administration with warfarin significantly **increases warfarin metabolism**, resulting in **lower warfarin concentrations** and a **decreased INR**.
Drug Interactions Indian Medical PG Question 4: Which of the following medications does not interact with warfarin?
- A. Barbiturate
- B. Oral contraceptive
- C. Cephalosporins
- D. Benzodiazepines (Correct Answer)
Drug Interactions Explanation: ***Benzodiazepines***
- **Benzodiazepines** are generally considered safe to use with warfarin as they are extensively metabolized in the liver, but they do not typically alter the **cytochrome P450 enzymes** responsible for warfarin metabolism.
- They also do not interfere with **vitamin K recycling** or **platelet function**, which are key mechanisms through which other drugs interact with warfarin.
*Barbiturate*
- **Barbiturates** are **potent inducers of hepatic enzymes**, particularly CYP2C9, which is responsible for metabolizing warfarin.
- This enzyme induction leads to **increased warfarin metabolism**, reducing its anticoagulant effect and necessitating higher warfarin doses.
*Oral contraceptive*
- **Oral contraceptives** can **reduce the anticoagulant effect of warfarin** by inducing clotting factors or inhibiting warfarin metabolism.
- This interaction can increase the risk of **thromboembolic events** in patients on warfarin.
*Cephalosporins*
- Certain **cephalosporins**, especially those with a **methylthiotetrazole (MTT) side chain** (e.g., Cefamandole, Cefoperazone, Moxalactam), can **inhibit vitamin K epoxide reductase**.
- This inhibition leads to a **decrease in vitamin K-dependent clotting factors**, thus potentiating the anticoagulant effect of warfarin and increasing bleeding risk.
Drug Interactions Indian Medical PG Question 5: Which drug should not be given with ketoconazole?
- A. Indinavir (Correct Answer)
- B. Macrolide
- C. All of the options
- D. Aminoglycoside
Drug Interactions Explanation: ***Correct: Indinavir***
- **Indinavir** is a **protease inhibitor (antiretroviral)** that is primarily metabolized by **CYP3A4**
- **Ketoconazole** is a **potent CYP3A4 inhibitor** that significantly increases indinavir plasma concentrations
- Co-administration leads to **increased risk of indinavir toxicity** including nephrolithiasis, hyperbilirubinemia, and hepatotoxicity
- **Dose reduction of indinavir is required** if concurrent use is necessary (typically reduce to 600 mg q8h from 800 mg q8h)
*Incorrect: Macrolide*
- Many **macrolides** (erythromycin, clarithromycin) are CYP3A4 substrates and can interact with ketoconazole
- While caution is advised due to **QT prolongation risk**, this interaction is less severe than with indinavir
- Not an absolute contraindication but requires monitoring
*Incorrect: Aminoglycoside*
- **Aminoglycosides** (gentamicin, amikacin, tobramycin) are **NOT metabolized by CYP450 enzymes**
- They are **hydrophilic** and eliminated **unchanged by renal excretion**
- **No clinically significant interaction** with ketoconazole
- Can be safely co-administered without dose adjustment
*Key Learning Point*
- Ketoconazole inhibits CYP3A4, affecting metabolism of many drugs including **protease inhibitors, calcium channel blockers, statins, and some macrolides**
- Always check for CYP3A4 substrate drugs when prescribing azole antifungals
Drug Interactions Indian Medical PG Question 6: The anticoagulant activity of warfarin can be reduced by all of the following except.
- A. Aspirin (Correct Answer)
- B. Rifampin
- C. Vitamin K
- D. Carbamazepine
Drug Interactions Explanation: ***Aspirin***
- **Aspirin** does NOT reduce warfarin's anticoagulant activity; instead, it increases the risk of bleeding through a synergistic effect.
- Aspirin inhibits platelet aggregation via **cyclooxygenase-1 (COX-1)** inhibition, preventing thromboxane A2 formation, which is a different mechanism from warfarin's inhibition of vitamin K-dependent clotting factors.
- When combined with warfarin, aspirin **potentiates** the overall antithrombotic effect and increases bleeding risk.
*Carbamazepine*
- **Carbamazepine** is a potent inducer of hepatic cytochrome P450 enzymes (CYP2C9, CYP3A4).
- By increasing warfarin metabolism, it **reduces** warfarin's plasma concentrations and decreases its anticoagulant effect.
- Patients on this combination may require higher warfarin doses to maintain therapeutic INR.
*Rifampin*
- **Rifampin** is one of the most potent inducers of hepatic cytochrome P450 enzymes (CYP2C9, CYP3A4).
- It significantly increases warfarin metabolism, leading to **reduced** plasma concentrations and diminished anticoagulant effect.
- This interaction often necessitates substantial increases in warfarin dosage.
*Vitamin K*
- **Vitamin K** is the direct antagonist of warfarin's mechanism of action.
- Warfarin inhibits vitamin K epoxide reductase, preventing the regeneration of active vitamin K needed for synthesis of clotting factors II, VII, IX, and X.
- Administration of vitamin K **reverses** warfarin's anticoagulant effect by bypassing the inhibited enzyme and restoring clotting factor production.
Drug Interactions Indian Medical PG Question 7: With which of the following receptors does theophylline have an antagonistic interaction?
- A. Histamine receptors
- B. Adenosine receptors (Correct Answer)
- C. Imidazoline receptors
- D. Bradykinin receptors
Drug Interactions Explanation: ***Adenosine receptors***
- **Theophylline** acts as a **non-selective competitive antagonist** at **adenosine receptors** (A1, A2A, and A2B).
- This antagonism contributes to its **bronchodilator effects** by blocking adenosine-induced bronchoconstriction and to its **stimulant effects** by enhancing neurotransmitter release.
*Histamine receptors*
- Theophylline does not primarily interact with **histamine receptors**. Its effects are mediated through different mechanisms.
- While histamine plays a role in allergic reactions and airway smooth muscle contraction, theophylline's direct action is not on these receptors.
*Imidazoline receptors*
- Theophylline does not have a significant antagonistic interaction with **imidazoline receptors**.
- These receptors are primarily involved in blood pressure regulation and sympathetic outflow, and are not a key target for theophylline's therapeutic effects.
*Bradykinin receptors*
- Theophylline does not directly antagonize **bradykinin receptors**.
- Bradykinin is a potent vasodilator and inflammatory mediator, but its receptors are not the primary site of action for theophylline.
Drug Interactions Indian Medical PG Question 8: Which of the following combinations can result in severe toxicity due to inhibition of cytochrome P450 enzymes?
- A. Amiodarone + Atorvastatin
- B. Carbamazepine + Atorvastatin
- C. Atorvastatin + Itraconazole (Correct Answer)
- D. Phenytoin + Atorvastatin
Drug Interactions Explanation: ***Atorvastatin + Itraconazole***
- **Itraconazole** is a potent inhibitor of **CYP3A4**, the primary enzyme responsible for atorvastatin's metabolism.
- Co-administration leads to significantly increased **atorvastatin plasma concentrations**, raising the risk of severe side effects like **rhabdomyolysis** and **hepatotoxicity**.
*Amiodarone + Atorvastatin*
- **Amiodarone** is a moderate **CYP3A4 inhibitor** and can increase atorvastatin levels, but the inhibition is **less potent** than itraconazole.
- While this combination does carry a risk and requires dose adjustment, the interaction is **less severe** compared to the potent inhibition seen with itraconazole.
- The direct CYP inhibition leading to severe atorvastatin toxicity is less pronounced than with itraconazole.
*Carbamazepine + Atorvastatin*
- **Carbamazepine** is a potent **CYP3A4 inducer**, meaning it would increase the metabolism of atorvastatin, potentially *decreasing* its efficacy rather than causing toxicity through inhibition.
- This interaction would typically lead to subtherapeutic atorvastatin levels, rather than severe toxicity.
*Phenytoin + Atorvastatin*
- **Phenytoin** is also a potent **CYP3A4 inducer**, similar to carbamazepine.
- Concurrent use would likely lead to enhanced metabolism and **reduced efficacy of atorvastatin**, not increased toxicity due to enzyme inhibition.
Drug Interactions Indian Medical PG Question 9: From which part of the Papaver somniferum plant does the latex, commonly referred to as 'milk', exude?
- A. Leaf of the plant
- B. Root of the plant
- C. Seeds of the plant
- D. Unripe capsule of the plant (Correct Answer)
Drug Interactions Explanation: ***Unripe capsule of the plant***
- The **latex** (or 'milk') containing **opioid alkaloids** like morphine and codeine is primarily harvested by incising the **unripe seed capsules** of the *Papaver somniferum* plant.
- This milky sap is then collected and dried to produce **crude opium**.
*Leaf of the plant*
- The leaves of *Papaver somniferum* do not contain significant amounts of the latex and are not the primary source of **opium alkaloids**.
- While some **alkaloids** might be present in trace amounts, they are not extracted commercially from the leaves.
*Root of the plant*
- The roots of the poppy plant are not known to exude latex or to be a significant source of medically relevant **opioid alkaloids**.
- Their primary function is absorption of water and nutrients, and anchoring the plant.
*Seeds of the plant*
- While the dried seeds are used for culinary purposes (poppy seeds), they contain very low levels of **opioid alkaloids** compared to the latex.
- The latex is produced within the **capsule** before the seeds fully mature.
Drug Interactions Indian Medical PG Question 10: A lady gets pregnant even though she was on contraceptive pills. She is suspected to have consumed
- A. Ciprofloxacin
- B. Rifampicin (Correct Answer)
- C. Streptomycin
- D. None of these
Drug Interactions Explanation: ***Rifampicin***
- **Rifampicin** is a potent inducer of **hepatic microsomal enzymes** (cytochrome P450 enzymes), particularly CYP3A4.
- This enzyme induction leads to increased metabolism and thus decreased effectiveness of **oral contraceptive pills**, raising the risk of unintended pregnancy.
*Ciprofloxacin*
- **Ciprofloxacin** is a **quinolone antibiotic** that primarily works by inhibiting bacterial DNA gyrase and topoisomerase IV.
- It does not significantly induce hepatic enzymes or interfere with the efficacy of **oral contraceptive pills**.
*Streptomycin*
- **Streptomycin** is an **aminoglycoside antibiotic** that inhibits bacterial protein synthesis.
- It is not known to have a significant drug interaction with **oral contraceptive pills** that would lead to contraceptive failure.
*None of these*
- This option is incorrect because **Rifampicin** is well-documented to reduce the effectiveness of **oral contraceptive pills**.
More Drug Interactions Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
